跳至主要内容
临床试验/EUCTR2013-004342-42-NL
EUCTR2013-004342-42-NL进行中(未招募)不适用

The effect of fish oil supplements on hemorheological parameters and walking distance in patients with intermittent claudication - FISHTIC

Medisch Centrum Alkmaar0 个研究点开始时间: 2014年1月3日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Newly diagnosed intermittent claudication
  • Ankle Brachial Index < 0.8 at rest or > 0.15 decrease after exercise
  • Able to perform standardized treadmill walking test for 2 min
  • Written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 36

排除标准

  • Unable to fill out a questionnaire (cognitive impairment or insufficient knowledge of the Dutch language)
  • Heart failure or unstable cardiac status (angina pectoris NYHA class III or IV or recent myocardial infarction < 3 months)
  • Any illness with rapid evolution or a life expectancy < 3 months
  • Recent cerebrovascular accident (< 3 months)
  • Current use of fish oil supplements or > 2 times a week dietary fish
  • Fish, soybean or peanut allergy
  • Contra indications for the use of omega-3 fatty acids
  • - use of oral anticoagulants (coumarin derivatives)

研究者

发起方
Medisch Centrum Alkmaar

相似试验